The role of fibroblast growth factors in vascular development

被引:222
作者
Javerzat, S [1 ]
Auguste, P [1 ]
Bikfalvi, A [1 ]
机构
[1] Univ Bordeaux 1, INSERM, EMI 0113, Mol Mech Angiogenesis & Growth Factor & Cell Diff, F-33405 Talence, France
关键词
D O I
10.1016/S1471-4914(02)02394-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast growth factors (FGFs) are considered angiogenic factors, yet the exact relationship between FGF and vascular development in normal and pathological tissue has long remained elusive. However, recent results from gene inactivation and transgenic studies in mice and in culture systems have demonstrated the role of FGFs in vessel assembly and sprouting. FGFs also promote blood-vessel branching and induce lymphangiogenesis. Novel players in FGF-mediated angiogenesis have been identified, such as p38 mitogen-activated protein kinase. Tumour angiogenesis is regulated by FGFs directly or indirectly via secondary angiogenesis factors, such as vascular endothelial growth factor. The newly established angiogenic role of FGFs makes FGF or molecules targeting FGF and its receptor promising candidates for the development of novel therapeutics.
引用
收藏
页码:483 / 489
页数:7
相关论文
共 70 条
[1]  
[Anonymous], FASEB J
[2]   Nuclear activities of basic fibroblast growth factor: Potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals [J].
Arese, M ;
Chen, Y ;
Florkiewicz, RZ ;
Gualandris, A ;
Shen, B ;
Rifkin, DB .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) :1429-1444
[3]   Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development [J].
Arman, E ;
Haffner-Krausz, R ;
Chen, Y ;
Heath, JK ;
Lonai, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5082-5087
[4]   Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb [J].
Arras, M ;
Ito, WD ;
Scholz, D ;
Winkler, B ;
Schaper, J ;
Schaper, W .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :40-50
[5]  
Auguste P, 2001, CANCER RES, V61, P1717
[6]   Semirational design of a potent, artificial agonist of fibroblast growth factor receptors [J].
Ballinger, MD ;
Shyamala, V ;
Forrest, LD ;
Deuter-Reinhard, M ;
Doyle, LV ;
Wang, JX ;
Panganiban-Lustan, L ;
Stratton, JR ;
Apell, G ;
Winter, JA ;
Doyle, MV ;
Rosenberg, S ;
Kavanaugh, WM .
NATURE BIOTECHNOLOGY, 1999, 17 (12) :1199-1204
[7]   DIFFERENTIAL MODULATION OF CELL PHENOTYPE BY DIFFERENT MOLECULAR-WEIGHT FORMS OF BASIC FIBROBLAST GROWTH-FACTOR - POSSIBLE INTRACELLULAR SIGNALING BY THE HIGH-MOLECULAR-WEIGHT FORMS [J].
BIKFALVI, A ;
KLEIN, S ;
PINTUCCI, G ;
QUARTO, N ;
MIGNATTI, P ;
RIFKIN, DB .
JOURNAL OF CELL BIOLOGY, 1995, 129 (01) :233-243
[8]   Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[9]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[10]  
Compagni A, 2000, CANCER RES, V60, P7163